CClinicalTrials.gg
CompletedNCT05744258BIA-IBSUpdated May 29, 2025Results posted

The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome

An interventional study of Bio-electrical impedance analysis in Irritable Bowel Syndrome, sponsored by Universitair Ziekenhuis Brussel. Completed at 1 site in Belgium. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-29.

Sponsored by Universitair Ziekenhuis Brussel · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Aug 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The study aim is to investigate the Bio-electrical Impedance (BIA) parameters in general, and phase angle (PhA) in particular in Irritable bowel syndrome (IBS) patients and to compare these with values from healthy controls, while assessing the relationship with other confounding parameters in IBS: psychological parameters, physical activity, dietary pattern (with special interest in FODMAP intake). In a second phase, the evolution of the BIA parameters will be analyzed according to response to therapy.

Read the detailed description

The role and significance of bio-electrical impedance analysis (BIA) has not been studied in IBS. Therefore, The investigators designed this exploratory study to assess its potential role in the diagnosis and follow-up of treatment in IBS. The study aim is to investigate the BIA parameters in general, and PhA in particular in IBS patients and to compare these with values from healthy controls, while assessing the relationship with other confounding parameters in IBS: psychological parameters, physical activity, dietary pattern (with special interest in FODMAP intake). In a second phase, the evolution of the BIA parameters will be analyzed according to response to therapy.

The primary objective is to compare the BIA parameters including PhA between IBS and healthy individuals.

02

Conditions studied

  • Irritable Bowel Syndrome
03

In context

Irritable Bowel Syndrome

1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.

This study's enrollment of 40 is below the median of 71 across 853 interventional studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

Universitair Ziekenhuis Brussel is the lead sponsor of 362 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients aged 18 - 75 years;
  • Fulfilling the ROME IV criteria for IBS (only for patients);

Exclusion criteria

Exclusion Criteria:

  • Clinical suspicion of an organic disorder different from IBS (patients can be included when this disorder had been excluded);
  • Known inflammatory bowel disorder;
  • Known major intestinal motility disorder;
  • Alcohol (defined as more than 14 U per week) or other substance abuse;
  • Active psychiatric disorder;
  • Known systemic or auto-immune disorder with implication for the GI system;
  • Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy);
  • Any prior diagnosis of cancer other than basocellular carcinoma;
  • Current chemotherapy;
  • History of gastro-enteritis in the past 12 weeks;
  • Dietary supplements unless taken at a stable dose for more than 12 weeks;
  • Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed);
  • Pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Other
    IBS patients

    Device: Bio-electrical impedance analysis

  • Other
    Healthy volunteers

    Device: Bio-electrical impedance analysis

Interventions

  • DeviceBio-electrical impedance analysis

    Bio-electrical Impedance Analysis will be performed by trained personnel. BIA will be performed after fasting for at least 6 hours. Subjects should refrain from intensive physical activity the day be-fore the measurement. For women, measurements will be performed outside menstruating periods. Subjects will lay down on an examination couch with bare feet. Any jewelry will be removed. Reactance and resistance will be obtained. Phase angle will be calculated according to the formula: PhA (°) = (reactance/ resistance° x (180°/π). Body composition, including muscle mass and percentage body fat will be calculated.

06

What researchers measure

Primary outcomes

  1. Comparison of the Phase Angle Between IBS Patients and Healthy Individuals

    Bio-electrical Impedance Analysis will be performed by trained personnel. BIA will be performed after fasting for at least 6 hours. Subjects should refrain from intensive physical activity the day be-fore the measurement. For women, measurements will be performed outside menstruating periods. Subjects will lay down on an examination couch with bare feet. Any jewelry will be removed. Reactance and resistance will be obtained. Phase angle will be calculated according to the formula: PhA (°) = (reactance/ resistance° x (180°/π).

    Time frame: The phase angle will be assessed through study completion, an average 6 months

  2. Comparison of the Percentage of Total Body Water Between IBS Patients and Healthy Individuals

    percentage of total body water will be calculated using the measurements obtained during the BIA analysis.

    Time frame: The body composition will be assessed through study completion, an average 6 months

  3. Comparison of the Muscle Mass Between IBS Patients and Healthy Individuals

    The muscle mass will be calculated using the measurements obtained during the BIA analysis.

    Time frame: the muscle mass will be assessed through study completion, an average 6 months

  4. Comparison of the Percentage of Body Fat Between IBS Patients and Healthy Individuals

    percentage of body fat will be calculated using the measurements obtained during the BIA analysis.

    Time frame: the percentage of body fat will be assessed through study completion, an average 6 months

07

Results

Posted May 29, 2025

Participant flow

Our first patient was recruited on the 22nd of August 2022. The last patient entered the study on 15JUN2023. Patients with IBS were recruited at the gastro-enterology department. Healthy volunteers were asked to participate in the hospital.

Participant flow — Overall Study
MilestoneIBS PatientsHealthy Volunteers
Started2020
Completed1620
Not completed40

Outcome measures

PrimaryComparison of the Phase Angle Between IBS Patients and Healthy Individuals

Bio-electrical Impedance Analysis will be performed by trained personnel. BIA will be performed after fasting for at least 6 hours. Subjects should refrain from intensive physical activity the day be-fore the measurement. For women, measurements will be performed outside menstruating periods. Subjects will lay down on an examination couch with bare feet. Any jewelry will be removed. Reactance and resistance will be obtained. Phase angle will be calculated according to the formula: PhA (°) = (reactance/ resistance° x (180°/π).

Time frame:
The phase angle will be assessed through study completion, an average 6 months
Reported as:
Median · degrees
Comparison of the Phase Angle Between IBS Patients and Healthy Individuals
degreesIBS PatientsHealthy Volunteers
Comparison of the Phase Angle Between IBS Patients and Healthy Individuals5.78 ± 0.536.35 ± 0.65
PrimaryComparison of the Percentage of Total Body Water Between IBS Patients and Healthy Individuals

percentage of total body water will be calculated using the measurements obtained during the BIA analysis.

Time frame:
The body composition will be assessed through study completion, an average 6 months
Reported as:
Median · % of total body water
Comparison of the Percentage of Total Body Water Between IBS Patients and Healthy Individuals
% of total body waterIBS PatientsHealthy Volunteers
Comparison of the Percentage of Total Body Water Between IBS Patients and Healthy Individuals63.4 ± 9.872.3 ± 7.8
PrimaryComparison of the Muscle Mass Between IBS Patients and Healthy Individuals

The muscle mass will be calculated using the measurements obtained during the BIA analysis.

Time frame:
the muscle mass will be assessed through study completion, an average 6 months
Reported as:
Median · % of muscle mass
Comparison of the Muscle Mass Between IBS Patients and Healthy Individuals
% of muscle massIBS PatientsHealthy Volunteers
Comparison of the Muscle Mass Between IBS Patients and Healthy Individuals42.9 ± 6.3952.6 ± 5.44
PrimaryComparison of the Percentage of Body Fat Between IBS Patients and Healthy Individuals

percentage of body fat will be calculated using the measurements obtained during the BIA analysis.

Time frame:
the percentage of body fat will be assessed through study completion, an average 6 months
Reported as:
Mean · % of fat free mass
Comparison of the Percentage of Body Fat Between IBS Patients and Healthy Individuals
% of fat free massIBS PatientsHealthy Volunteers
Comparison of the Percentage of Body Fat Between IBS Patients and Healthy Individuals46.8 ± 6.853.7 ± 3.8

Adverse events

Collected over from enrollment until end of follow up, up to 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
IBS Patients0/20 (0%)0/20 (0%)0/20 (0%)
Healthy Volunteers0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)IBS PatientsHealthy VolunteersTotal
<=18 years000
Between 18 and 65 years161935
>=65 years011
Sex: Female, Male
Sex: Female, Male(Participants)IBS PatientsHealthy VolunteersTotal
Female14923
Male21113
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)IBS PatientsHealthy VolunteersTotal
Count of participants——0
BMI
BMI(kg/m2)IBS PatientsHealthy VolunteersTotal
Median27.23 ± 6.4623.77 ± 3.7625.54 ± 5.11
08

Study locations

1 site
  • UZ Brussel
    Brussel, Brussels 1090, Belgium
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 19, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05744258
Lead sponsor
Universitair Ziekenhuis Brussel
Responsible party
Sponsor
First posted
Feb 24, 2023
Start date
Aug 22, 2022
Primary completion
May 22, 2024
Completion
Mar 31, 2025
Results posted
May 29, 2025
Last update
May 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion